Antimalarial medicines procured by WHO

 

Malaria Prequalified Products PDF version Access to Artemisinin-based Combination Antimalarial Drugs,
of acceptable quality. Suppliers whose Artemisinin-based Combination Antimalarial
products have been found acceptable, in principle, for procurement by UN Agencies.

           
Antimalarial Medicines
available for procurement by WHO (Last updated: 03.06.2009)
International Non-Proprietary Name (INN) Strength Dosage form Supplier Packaging
Artemether / lumefantrine  20mg/120mg Fixed dose tablets

Ajanta, India
Cipla, India
Novartis, China
Novartis, USA

6x1 6x2
6x3 6x4
30 blisters / box
Ipca, India Single blisters
Dispersible tablets Novartis, USA 6x1
6x2
30 blisters / box
 
Artesunate
+
amodiaquine 
25mg+67.5mg Fixed dose tablets Sanofi Aventis 3 25 blisters / box
50mg+135mg
100mg+270mg
 
6
50mg + 150mg (base) Co-blistered tablets Guilin, China 3+3
6+6
12+12
25 blisters / box
50mg + 153mg (base) Cipla, India 25 blisters / box
Ipca, India   10 treatments / box
100 treatments / box
Strides, India   10 treatments / box
 
Artesunate
+
mefloquine 
200mg + 250mg Co-blistered tablets Mepha, Switzerland  3+6 Single blisters
 
Artesunate
+
sulfadoxine /
pyrimethamine 
50mg + 500/25mg Co-blistered tablets Cipla, India  3+1
 6+2
12+3
 Single blisters
100mg + 500/25mg Co-blistered tablets Guilin, China 6+3 Single blisters
 
Artemether 20mg/ml Injection Dafra, Belgium     3 Ampoules / pack
10 Ampoules / pack 
80mg/ml   5 Ampoules / pack
 

 

RELATED LINKS

WHO Prequalification Programme

The Prequalification Programme was created by the World Health Organization in 2001.  It aims to increase access to priority medicinal products that meet unified standards of acceptable quality, safety and efficacy, currently focusing on those used for HIV/AIDS, Malaria, Tuberculosis and for Reproductive Health.